mRNA vaccines — a new era in vaccinology

Cited by (1,011)

Items 401–500 of 1,011

1. Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA
   Blakney, Anna K., McKay, Paul F., Bouton, Clément R., Hu, Kai, Samnuan, Karnyart, Shattock, Robin J. · 2021 · Molecular Therapy
2. Rapid development and deployment of high‐volume vaccines for pandemic response
   Kis, Zoltán, Kontoravdi, Cleo, Dey, Antu K., Shattock, Robin, Shah, Nilay · 2020 · Journal of Advanced Manufacturing and Processing
3. Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine
   Ya-Nan Fan, Min Li, Ying‐Li Luo, Qian Chen, Li Wang, Houbing Zhang, Song Shen, Zhen Gu, Jun Wang · 2018 · Biomaterials Science
4. Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
   Stephen C. Frederico, John C. Hancock, Emily E. S. Brettschneider, Nivedita M. Ratnam, Mark R. Gilbert, Masaki Terabe · 2021 · Frontiers in Oncology
5. Insights into new-onset autoimmune diseases after COVID-19 vaccination
   Ming Guo, Xiaoxiao Liu, Xiangmei Chen, Qinggang Li · 2023 · Autoimmunity Reviews
6. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
   Eric M. Mucker, Alec W. Freyn, Sandra L. Bixler, Deniz Cizmeci, Caroline G. Atyeo, Patricia L. Earl, Harini Natarajan, Genesis Santos, Tiffany R. Frey, Rafael H. Levin et al. · 2024 · Cell
7. Neo-Antigen mRNA Vaccines
   Arthur Esprit, Wout de Mey, Rajendra Bahadur Shahi, Kris Thielemans, Lorenzo Franceschini, Karine Breckpot · 2020 · Vaccines
8. Development of vaccines and antivirals for combating viral pandemics
   Norbert Pardi, Drew Weissman · 2020 · Nature Biomedical Engineering
9. mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
   Maryam Bidram, Yue Zhao, Natalia G. Shebardina, Alexey V. Baldin, Alexandr V. Bazhin, Mohamad Reza Ganjalikhany, Andrey A. Zamyatnin, Mazdak Ganjalıkhani-Hakemi · 2021 · Vaccines
10. Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo
    Zhaoming Chen, Yang Tian, Jieyu Yang, Fapu Wu, Senyao Liu, Wenwen Cao, Weijia Xu, Tao Hu, Daniel J. Siegwart, Hu Xiong · 2023 · Journal of the American Chemical Society
11. Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective
    Mubashar Rehman, Nayab Tahir, Muhammad Farhan Sohail, Muhammad Usman Qadri, Sofia O. D. Duarte, Pedro Brandão, Teresa Esteves, Ibrahim Javed, Pedro Fonte · 2024 · Pharmaceutics
12. Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases
    Guoyu Yang, Sheng Chen, Jianxiang Zhang · 2019 · Frontiers in Pharmacology
13. Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs
    Qing Li, Ching Shen Chan, Norman C. Peterson, Richard N. Hanna, Alex Alfaro, Kevin L. Allen, Herren Wu, William F. Dall’Acqua, M. Jack Borrok, José Luís Santos · 2020 · ACS Chemical Biology
14. Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
    Zimei Wu, Tonglei Li · 2021 · Pharmaceutical Research
15. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
    Giulia Anderluzzi, Gustavo Lou, Stuart Woods, S. Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner et al. · 2021 · Journal of Controlled Release
16. Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy
    Han Liu, Hao Zhang, Yafei Han, Yan Hu, Zhen Geng, Jiacan Su · 2022 · Theranostics
17. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
    Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya, Kevin J. Wiehe, Barton F. Haynes · 2020 · Cell
18. Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
    Na Fan, Kepan Chen, Rong Zhu, Zhongwei Zhang, Hai Huang, Shugang Qin, Qian Zheng, Zhongshan He, Xi He, Wen Xiao et al. · 2022 · Science Advances
19. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge
    Fujun Hou, Yuntao Zhang, Xiaohu Liu, Yanal M. Murad, Jiang Xu, Zhibin Yu, Xianwu Hua, Yingying Song, Jun Ding, Hongwei Huang et al. · 2023 · Nature Communications
20. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
    Shen Wang, Wujian Li, Zhenshan Wang, Wanying Yang, Entao Li, Xianzhu Xia, Feihu Yan, Sandra Chiu · 2024 · Signal Transduction and Targeted Therapy
21. The advent of clinical self-amplifying RNA vaccines
    Irafasha C. Casmil, Jongwoo Jin, Eun-Jeong Won, Cynthia Huang, Suiyang Liao, Hyunjoo Cha‐Molstad, Anna K. Blakney · 2025 · Molecular Therapy
22. Previous COVID-19 Infection and Antibody Levels After Vaccination
    Hamad Ali, Barrak Alahmad, Abdullah A. Al‐Shammari, Abdulmohsen Alterki, Maha M. Hammad, Preethi Cherian, Irina Al‐Khairi, Sardar T. A. K. Sindhu, Thangavel Alphonse Thanaraj, Anwar Mohammad et al. · 2021 · Frontiers in Public Health
23. Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
    Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, Chiaowen Joyce Hsiao, Anne S. Golding, Albert B. Jeon, Eric Jacquinet, Emily Azcue, Chenxia Monica Guan, Xavier Sanchez-Felix et al. · 2023 · Science Advances
24. Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives
    Yang Shi · 2020 · Advanced Therapeutics
25. Advances in gene-based vaccine platforms to address the COVID-19 pandemic
    Deborah Pushparajah, Salma Jimenez, Shirley Lau Wong, Hibah Alattas, Nafiseh Nafissi, Roderick Adrian Slavcev · 2021 · Advanced Drug Delivery Reviews
26. RNA-based therapies: A cog in the wheel of lung cancer defense
    Parvez Κhan, Jawed Akhtar Siddiqui, Imayavaramban Lakshmanan, Apar Kishor Ganti, Ravi Salgia, Maneesh Jain, Surinder K. Batra, Mohd Wasim Nasser · 2021 · Molecular Cancer
27. COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines
    Ishan Garg, Rahul Shekhar, Abu Baker Sheikh, Suman Pal · 2021 · Infectious Disease Reports
28. Myocardial Injury Pattern at MRI in COVID-19 Vaccine–Associated Myocarditis
    Matteo Fronza, Paaladinesh Thavendiranathan, Victor Siang Hua Chan, Gauri Rani Karur, Jacob Allen Udell, Rachel Maya Wald, Rachel Hong, Kate A Hanneman · 2022 · Radiology
29. Twenty Years of Progress Toward West Nile Virus Vaccine Development
    Jaclyn A. Kaiser, Alan D.T. Barrett · 2019 · Viruses
30. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid
    Qiao Tang, Ji Liu, Ying Yan Jiang, Meining Zhang, Lanqun Mao, Ming Wang · 2019 · ACS Applied Materials & Interfaces
31. Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine—Specific Cancer Targeting with Undetectable Toxicity
    Daniel W. Binzel, Xin Li, Nicolas Burns, Eshan Khan, Wen-Jui Lee, Li-Ching Chen, Satheesh Ellipilli, Wayne O. Miles, Yuan Soon Ho, Peixuan Guo · 2021 · Chemical Reviews
32. Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
    Jilian R. Melamed, Khalid A. Hajj, Namit Chaudhary, Daria Strelkova, Mariah Lynn Arral, Norbert Pardi, Mohamad‐Gabriel Alameh, Jason B. Miller, Lukas Farbiak, Daniel J. Siegwart et al. · 2021 · Journal of Controlled Release
33. RNA therapeutics in the clinic
    Alexander M. Curreri, Disha Sankholkar, Samir Mitragotri, Zongmin Zhao · 2022 · Bioengineering & Translational Medicine
34. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
    Kang, Diana D., Li, Haoyuan, Dong, Yizhou · 2023 · Advanced Drug Delivery Reviews
35. Self-Amplifying RNA Viruses as RNA Vaccines
    Kenneth H. Lundstrom · 2020 · International Journal of Molecular Sciences
36. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
    Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine K. Macartney, Fiona Mary Russell, Benjamin W. Teh, Sophie Chien-Hui Wen · 2020 · Frontiers in Immunology
37. Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing
    Qiubing Chen, Ying Zhang, Hao Yin · 2020 · Advanced Drug Delivery Reviews
38. Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
    Navid Sobhani, Bruna Scaggiante, Rachel M. Morris, Dafei Chai, Martina Catalano, Dana Rae Tardiel-Cyril, Praveen Kumar Neeli, Giandomenico Roviello, Giuseppina Mondani, Yong Li · 2022 · Cancer Treatment Reviews
39. Safety and efficacy of COVID‐19 vaccines: A systematic review and meta‐analysis of controlled and randomized clinical trials
    Beladiya, Jayesh, Kumar, Anup, Vasava, Yogesh, Parmar, Krupanshu, Patel, Dipanshi, Patel, Sandip, Dholakia, Sandip, Sheth, Devang, Boddu, Sai H. S., Patel, Chirag · 2024 · Reviews in Medical Virology
40. Advances in RNA vaccines for preventive indications: A case study of a vaccine against rabies
    Armbruster, Nicole, Jasny, Edith, Petsch, Benjamin · 2019 · Vaccines
41. Application of Nanotechnology in the COVID-19 Pandemic
    Dongki Yang · 2021 · International Journal of Nanomedicine
42. Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
    Chi Zhang, Yifan Ma, Jingjing Zhang, Jimmy Chun‐Tien Kuo, Zhongkun Zhang, Haotian Xie, Jing Zhu, Tongzheng Liu · 2022 · Molecules
43. Exosome-Based Carrier for RNA Delivery: Progress and Challenges
    Yicheng Lu, Wei Chieh Huang, Meng Li, Aiping Zheng · 2023 · Pharmaceutics
44. The advances of adjuvants in mRNA vaccines
    Chunyuan Xie, Ruhui Yao, Xiaojun Xia · 2023 · npj Vaccines
45. Developing a SARS-CoV-2 Vaccine at Warp Speed
    O’Callaghan, Kevin P., Blatz, Allison M., Offit, Paul A. · 2020 · JAMA
46. Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination
    Sejin Son, Jutaek Nam, Ilia Zenkov, Lukasz J. Ochyl, Yao Xu, Lindsay M. Scheetz, Jinjun Shi, Omid Cameron Farokhzad, James Jaehyun Moon · 2020 · Nano Letters
47. A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
    Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, Ali Dehshahri, Afsaneh Vazin · 2021 · International Immunopharmacology
48. Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy
    Jiali Yang, Jiafeng Zhu, Jiaojiao Sun, Yiyun Chen, Yaran Du, Yiling Tan, Linpeng Wu, Mengting Zhai, Lixiang Wei, Na Li et al. · 2022 · Molecular Therapy — Nucleic Acids
49. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
    Cynthia Calzas, Christophe Chevalier · 2019 · Frontiers in Immunology
50. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China
    Meixian Zhang, Tong-Tong Zhang, Guifeng Shi, Fengmin Cheng, Yan-Ming Zheng, Tao‐Hsin Tung, Haixiao Chen · 2021 · Expert Review of Vaccines
51. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
    Mary M. Tomayko, William Damsky, Ramie A. Fathy, Devon E. McMahon, Noel Turner, Monica N. Valentin, Tena M. Rallis, Ohara Aivaz, Lindy Peta Fox, Esther Ellen Freeman · 2021 · Journal of Allergy and Clinical Immunology
52. Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
    Vivek P. Chavda, Md. Mer Mosharraf Hossain, Jayesh Beladiya, Vasso Apostolopoulos · 2021 · Biologics
53. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
    Xing Huang, Gang Zhang, Tianyu Tang, Xiang Gao, Tingbo Liang · 2022 · Military Medical Research
54. Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
    Jieun Han, Jaesung Lim, Chi‐Pin James Wang, Jun‐Hyeok Han, Ha Eun Shin, Se-Na Kim, Dooyong Jeong, Sang Hwi Lee, Bok-Hwan Chun, Chun Gwon Park et al. · 2023 · Nano Convergence
55. The Promise and Potential of Metal–Organic Frameworks and Covalent Organic Frameworks in Vaccine Nanotechnology
    Yalini H. Wijesundara, Thomas Sinclair Howlett, Sneha Kumari, Jeremiah J. Gassensmith · 2024 · Chemical Reviews
56. DNA vaccination for finfish aquaculture
    Catherine Collins, Niels Lorenzen, Bertrand Collet · 2018 · Fish & Shellfish Immunology
57. Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
    Leroy Versteeg, Mashal M. Almutairi, Peter Jay Hotez, Jeroen B. K. Pollet · 2019 · Vaccines
58. The 2020 race towards SARS-CoV-2 specific vaccines
    Tomasz M. M Karpiński, Marcin Ożarowski, Agnieszka Seremak‐Mrozikiewicz, Hubert Wolski, Donald Włodkowic · 2020 · Theranostics
59. Use of Protamine in Nanopharmaceuticals—A Review
    Ivana Ruseska, Katja Fresacher, Christina Petschacher, Andreas Zimmer · 2021 · Nanomaterials
60. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
    Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki, Taro Kawai · 2021 · Frontiers in Cellular and Infection Microbiology
61. Sustained delivery approaches to improving adaptive immune responses
    Ben S. Ou, Olivia M. Saouaf, Julie Baillet, Eric Andrew Appel · 2022 · Advanced Drug Delivery Reviews
62. Engineering nanoparticle toolkits for mRNA delivery
    Bing Sun, Weixi Wu, Eshan A. Narasipura, Yutian Ma, Chengzhong Yu, Owen S. Fenton, Hao Song · 2023 · Advanced Drug Delivery Reviews
63. DNA Origami: From Molecular Folding Art to Drug Delivery Technology
    Qiao Jiang, Yingxu Shang, Yiming Xie, Baoquan Ding · 2023 · Advanced Materials
64. Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones
    Iosif Tammas, Konstantina Bitchava, Athanasios Ι. Gelasakis · 2024 · Vaccines
65. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations
    Stafford, Irene A., Parchem, Jacqueline G., Sibai, Baha M. · 2021 · American Journal of Obstetrics and Gynecology
66. Influenza vaccine: Where are we and where do we go?
    Mohsen Keshavarz, Hamed Mirzaei, Maryam Salemi, Fatemeh Momeni, Mohammad Javad Mousavi, Mona Sadeghalvad, Yaser Arjeini, Farid Solaymani‐Mohammadi, Javid Sadri Nahand, Haideh Namdari et al. · 2018 · Reviews in Medical Virology
67. Current Advances in Zika Vaccine Development
    Yuchen Wang, Lin Ling, Zilei Zhang, Alejandro Marín-López · 2022 · Vaccines
68. Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
    Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, Dan Liu, Kongshuo Ma, Mengli Zhou, Kaiqing Yun, Lang Rao, Zhaohui Wang · 2024 · Advanced Materials
69. Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
    Hojeong Shin, S.D. Park, Yeajee Yim, Jungho Kim, Chulwon Choi, Cheolhee Won, Dal‐Hee Min · 2018 · Advanced Therapeutics
70. SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
    Saborni Chakraborty, Vamsee V. A. Mallajosyula, Cristina M. Tato, Gene S. Tan, Taia T. Wang · 2021 · Advanced Drug Delivery Reviews
71. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
    Kevin O. Saunders, Norbert Pardi, Robert Parks, Sampa Santra, Zekun Mu, Laura L. Sutherland, Richard M. Scearce, Maggie Barr, Amanda Eaton, Giovanna E. Hernandez et al. · 2021 · npj Vaccines
72. Frameworks for transformational breakthroughs in RNA-based medicines
    John R. Androsavich · 2024 · Nature Reviews Drug Discovery
73. RNA chemistry and therapeutics
    Siyu Wang, Drew Weissman, Yizhou Dong · 2025 · Nature Reviews Drug Discovery
74. Zika Virus Vaccine Development: Progress in the Face of New Challenges
    Michael Diamond, Julie E. Ledgerwood, Theodore C. Pierson · 2018 · Annual Review of Medicine
75. RNA Therapy: Current Status and Future Potential
    Young‐Kook Kim · 2020 · Chonnam Medical Journal
76. Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
    Sarah Creytens, Mirte N. Pascha, Marlies Ballegeer, Xavier Saelens, Cornelis A. M. de Haan · 2021 · Frontiers in Immunology
77. Current approaches to HIV vaccine development: a narrative review
    Jiae Kim, Sandhya Vasan, Jérôme H. Kim, Julie A. Ake · 2021 · Journal of the International AIDS Society
78. A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery
    Alana Gerhardt, Emily A. Voigt, Michelle C. Archer, Sierra Reed, Elise Larson, Neal Van Hoeven, Ryan M. Kramer, Christopher B. Fox, Corey Casper · 2022 · Molecular Therapy — Methods & Clinical Development
79. COVID-19 vaccines adverse events: potential molecular mechanisms
    Malamatenia Lamprinou, Athanasios Sachinidis, Εleni Stamoula, Theofanis Vavilis, Georgios Papazisis · 2023 · Immunologic Research
80. Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape
    Xiang Li, Jing Qi, Juan Wang, Weiwei Hu, Weichang Zhou, Yi Wang, Tao Li · 2024 · Theranostics
81. Synthetic modified messenger RNA for therapeutic applications
    Gao, Minsong, Zhang, Qingyi, Feng, Xin-Hua, Liu, Jianzhao · 2021 · Acta Biomaterialia
82. Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice
    Zhang, Mengling, Sun, Jin, Li, Min, Jin, Xia · 2020 · Molecular Therapy - Methods & Clinical Development
83. A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
    Voigt, Emily A., Gerhardt, Alana, Hanson, Derek, Jennewein, Madeleine F., Battisti, Peter, Reed, Sierra, Singh, Jasneet, Mohamath, Raodoh, Bakken, Julie, Beaver, Samuel et al. · 2022 · npj Vaccines
84. New Kids on the Block: RNA-Based Influenza Virus Vaccines
    Francesco Berlanda Scorza, Norbert Pardi · 2018 · Vaccines
85. Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA
    Satoshi Uchida, Kazunori Kataoka · 2019 · Journal of Biomedical Materials Research Part A
86. RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics
    Poonam R. Pandey, Ken H. Young, Dhiraj Kumar, Neeraj Kumar Jain · 2022 · Molecular Cancer
87. Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
    Allison August, Christine A. Shaw, Heather Ruth Lee, Conor Knightly, Shiva Kalidindia, Laurence Chu, Brandon J. Essink, William Seger, Tal Z. Zaks, Igor V. Smolenov et al. · 2022 · Open Forum Infectious Diseases
88. Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect
    Rahul Kumar, Daphika S. Dkhar, Rohini Kumari, divya divya divya, Supratim Mahapatra, Vikash Kumar Dubey, Pranjal Chandra · 2022 · Journal of Drug Delivery Science and Technology
89. 2′- O -Methylation of the second transcribed nucleotide within the mRNA 5′ cap impacts the protein production level in a cell-specific manner and contributes to RNA immune evasion
    Karolina Drążkowska, Rafał Tomecki, Marcin Warmiński, Natalia Baran, Dominik Cysewski, Anaïs Depaix, Renata Kasprzyk, Joanna Kowalska, Jacek Jemielity, Pawel J. Sikorski · 2022 · Nucleic Acids Research
90. Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines
    Rajendra Rohokale, Zhongwu Guo · 2023 · ACS Infectious Diseases
91. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy
    Oscar Escalona-Rayo, Ye Zeng, Renzo A. Knol, Thomas J. F. Kock, Dennis Aschmann, Bram Slütter, Alexander Kros · 2023 · Biomedicine & Pharmacotherapy
92. A new generation of vaccines based on alphavirus self-amplifying RNA
    María Cristina Ballesteros-Briones, Noelia Silva-Pilipich, Guillermo Herrador, Lucía Vanrell, Cristian Smerdou · 2020 · Current Opinion in Virology
93. COVID-19 mRNA vaccines
    Qingrui Huang, Jiawei Zeng, Jinghua Yan · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
94. Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis
    Haoyue Cheng, Zhicheng Peng, Wenliang Luo, Shuting Si, Minjia Mo, Haibo Zhou, Xing Xin, Hui Liu, Yunxian Yu · 2021 · Vaccines
95. Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
    Ai‐Ming Yu, Mei‐Juan Tu · 2021 · Pharmacology & Therapeutics
96. A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines
    Marek A. Kloczewiak, Jessica M. Banks, Lin Jin, Mark L. Brader · 2022 · Molecular Pharmaceutics
97. Recent progress in mRNA cancer vaccines
    Ruhui Yao, Chunyuan Xie, Xiaojun Xia · 2024 · Human Vaccines & Immunotherapeutics
98. Small circular RNAs as vaccines for cancer immunotherapy
    Yu Zhang, Xiang Liu, Tingting Shen, Qiyan Wang, Shurong Zhou, Suling Yang, Shimiao Liao, Ting Su, Lei Mei, Bei Zhang et al. · 2025 · Nature Biomedical Engineering
99. Self-assembled polymeric micelle as a novel mRNA delivery carrier
    Jin Ren, Yiming Cao, Lei Li, Xin Wang, Haitao Lü, Jing Yang, Shengqi Wang · 2021 · Journal of Controlled Release
100. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
     Ting Le, Chao Sun, Jitao Chang, Guijie Zhang, Xin Yin · 2022 · Viruses